NASDAQ: CLSN       Celsion Corp
Last Price Today's Change   Day's Range   Trading Volume
0.583   -0.047 (7.46%)  0.558 - 0.591  779,455


Avg Volume (4 weeks):793,245
4 Weeks Range:0.52 - 0.76
4 Weeks Price Volatility (%):
52 Weeks Range:0.52 - 6.50
52 Weeks Price Volatility (%):
Average Price Target: 6.00
Price Target Upside/Downside: +5.417


No recent Headlines for this stock.

Business Background

Celsion Corp is active in the biotechnology market. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in Phase III clinical trial for the treatment of primary liver cancer and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2350  3410  483  3145 

Top 10 Active Counters
 LK 1.38+1.38 
 ISIG 1.39+0.444 
 OAS 0.155-0.014 
 AMD 79.372-2.858 
 NIO 27.53+1.52 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 XOG 0.271-0.062 
 AAPL 116.16+1.11 
 SNAP 42.02+0.75